Niu, Y., & Zhu, S. (2016). AB187. Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality. Transl Androl Urol.
Citação norma ChicagoNiu, Yuanjie, and Shimiao Zhu. "AB187. Androgen Deprivation Therapy for Prostate Cancer Is Associated With Cardiovascular Morbidity and Mortality." Transl Androl Urol 2016.
MLA CitationNiu, Yuanjie, and Shimiao Zhu. "AB187. Androgen Deprivation Therapy for Prostate Cancer Is Associated With Cardiovascular Morbidity and Mortality." Transl Androl Urol 2016.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.